WDSUB1 inhibitors, also known as WDSUB1 (or simply WD40 repeat and SUB1 domain-containing protein 1) protein inhibitors, belong to a specific class of chemical compounds that are designed to interact with and modulate the activity of the WDSUB1 protein. The WDSUB1 protein is a member of the WD40 repeat protein family, which is characterized by the presence of WD40 repeats, structural motifs involved in protein-protein interactions. WD40 repeat proteins are ubiquitous in eukaryotic cells and play essential roles in various cellular processes, including signal transduction, cell cycle regulation, and gene expression. WDSUB1, in particular, has garnered attention due to its involvement in certain cellular functions, making it a target of interest for research and development.
WDSUB1 inhibitors are designed to specifically bind to the WDSUB1 protein, often at its active site or allosteric sites, to modulate its function. By doing so, these inhibitors affects the various cellular processes in which WDSUB1 is involved. The development and study of WDSUB1 inhibitors are part of ongoing research efforts to better understand the protein's role in cellular biology and its implications in various diseases. These inhibitors are valuable tools for researchers seeking to elucidate the molecular mechanisms in which WDSUB1 participates and may ultimately contribute to the development of novel strategies for addressing conditions associated with dysregulation of WDSUB1-related pathways. Further research into the precise mechanisms of WDSUB1 inhibition and its downstream effects will continue to shed light on its significance in cellular physiology.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
This compound specifically inhibits the activity of certain tyrosine kinases, notably BCR-ABL, by competitively binding to their ATP-binding sites. This prevents the phosphorylation of downstream signaling molecules, effectively inhibiting cellular proliferation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib operates as a proteasome inhibitor, impeding the degradation process of ubiquitinated proteins within cells, which results in an accumulation of misfolded proteins and subsequently induces apoptosis in cancer cells. |